Liliana R. Loureiro - Concepedia

Author

Liliana R. Loureiro

National Center for Tumor Diseases ORCID

Also Known As

L. LOUREIRO, L. Loureiro, L. R. Loureiro, Liliana Loureiro, Liliana R Loureiro, Liliana R. Loureiro, Liliana Rodrigues Loureiro, Loureiro, Liliana R.

Publications

877

Citations

H-Index

Concepts

All Affiliations

National Center for Tumor Diseases Helmholtz-Zentrum Dresden-Rossendorf University Hospital Carl Gustav Carus Technische Universität Dresden German Cancer Research Center

About

Liliana R. Loureiro is an author at National Center for Tumor Diseases specializing in medicine, tumor microenvironment, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	237
2	Natural Sciences	2	2	35
3	Biochemistry	2	2	35
4	Engineering	1	1	26
5	Biomolecular Engineering	1	1	26

Liliana R. Loureiro

Publications

593

Citations

H-Index

Page 1

	Year	Citations
“UniCAR”-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells Nicola Mitwasi, Anja Feldmann, Claudia Arndt, Scientific Reports Off-the-shelf Nk-92 CellsTumor BiologyRadiation OncologyCancer ImmunosurveillanceMedicine	2020	80
Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy Anja Feldmann, Anja Hoffmann, Ralf Bergmann, OncoImmunology Chimeric Antigen ReceptorCar T CellsDrug TargetingNovel TherapyAdaptive Immune System	2020	63
Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids Liliana R. Loureiro, Diana P. Sousa, Dylan Ferreira, Scientific Reports	2018	53
UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells Claudia Arndt, Liliana R. Loureiro, Anja Feldmann, OncoImmunology	2020	39
Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers Liliana R. Loureiro, Anja Feldmann, Ralf Bergmann, Journal of Experimental & Clinical Cancer Research	2020	34
Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy Enrico Kittel-Boselli, Karla Elizabeth González Soto, Liliana R. Loureiro, Cancers Mixed-phenotype Acute LeukemiaImmunologyImmunoeditingAntigen ProcessingImmunotherapeutics	2021	33
CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation Jiří Eitler, Wiebke Rackwitz, Natalie Wotschel, Journal for ImmunoTherapy of Cancer	2024	32
Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma Ayşe Sedef Köseer, Liliana R. Loureiro, Justyna Jureczek, Cancers	2022	26
Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1 Fabian Krutzek, Cornelius K. Donat, Martin Ullrich, Cancers EngineeringOncologic ImagingImaging AgentPd-1/pd-l1 Immune CheckpointTumor Biology	2023	26
oxSWATH: An integrative method for a comprehensive redox-centered analysis combined with a generic differential proteomics screening Sandra I. Anjo, Matilde N. Melo, Liliana R. Loureiro, Redox Biology	2019	25

Page 1